Literature DB >> 21381035

Autoantibody-induced intestinal inflammation and weight loss in experimental epidermolysis bullosa acquisita.

Norito Ishii1, Andreas Recke, Sidonia Mihai, Misa Hirose, Takashi Hashimoto, Detlef Zillikens, Ralf J Ludwig.   

Abstract

Type VII collagen (COL7) is a major constituent of the cutaneous basement membrane. Loss of tolerance to COL7 leads to the blistering skin disease epidermolysis bullosa acquisita (EBA). Antibodies to COL7 have also been detected in patients with inflammatory bowel disease (IBD), yet reports on the expression of COL7 in the gut are controversial and a pathogenic relevance of anti-COL7 autoantibodies in IBD has not been demonstrated. We therefore characterized the expression patterns of COL7 in murine gastrointestinal organs and investigated if anti-COL7 antibodies induce an inflammatory response in the gut. COL7 expression was analysed on the mRNA and protein levels. Mice were injected with rabbit anti-murine COL7 IgG (passive EBA) or immunized with a fragment of murine COL7 (active EBA). COL7 was found to be expressed in buccal mucosa, oesophagus, stomach, small intestine, and colon. In addition to skin blistering, in both passive and active EBA, autoantibodies bound to the gastrointestinal basement membrane, fixed complement, and led to recruitment of leukocytes. Furthermore, blister formation was observed in the oesophagus (40%/38% of mice in passive/active model), stomach (40%/63%), small intestine (20%/13%), and colon (20%/13%). Compared to control animals, we found a significantly reduced body weight in diseased mice, suggesting that autoantibody-induced gastrointestinal inflammation is clinically relevant. Those observations may help us to understand the co-incidence of IBD with EBA, and vice versa: The inflammatory response in IBD might expose novel antigens (COL7), which leads to the formation of anti-COL7 antibodies. On the contrary, anti-COL7 antibody-induced gastrointestinal inflammation might pave the way for IBD pathogenesis. In summary, our results provide strong evidence that COL7 is expressed in different portions of the gut and that anti-COL7 antibodies induce distinct gastrointestinal tissue damage.
Copyright © 2011 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21381035     DOI: 10.1002/path.2857

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  14 in total

1.  Granulocyte-dependent autoantibody-induced skin blistering.

Authors:  Kinga Csorba; Sebastian Sitaru; Cassian Sitaru
Journal:  J Vis Exp       Date:  2012-10-12       Impact factor: 1.355

Review 2.  Mechanisms of Autoantibody-Induced Pathology.

Authors:  Ralf J Ludwig; Karen Vanhoorelbeke; Frank Leypoldt; Ziya Kaya; Katja Bieber; Sandra M McLachlan; Lars Komorowski; Jie Luo; Otavio Cabral-Marques; Christoph M Hammers; Jon M Lindstrom; Peter Lamprecht; Andrea Fischer; Gabriela Riemekasten; Claudia Tersteeg; Peter Sondermann; Basil Rapoport; Klaus-Peter Wandinger; Christian Probst; Asmaa El Beidaq; Enno Schmidt; Alan Verkman; Rudolf A Manz; Falk Nimmerjahn
Journal:  Front Immunol       Date:  2017-05-31       Impact factor: 7.561

Review 3.  Subepidermal autoimmune bullous diseases: overview, epidemiology, and associations.

Authors:  Khalaf Kridin
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

Review 4.  Epidermolysis bullosa and the partnership with autoimmunity: what should we assimilate?

Authors:  Susanna Esposito; Sophie Guez; Francesca Manzoni; Annalisa Bosco; Donato Rigante
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

5.  Prevalence of collagen VII-specific autoantibodies in patients with autoimmune and inflammatory diseases.

Authors:  Emilia Licarete; Susanne Ganz; Martin J Recknagel; Giovanni Di Zenzo; Takashi Hashimoto; Michael Hertl; Giovanna Zambruno; Gheorghe Hundorfean; Jonas Mudter; Markus F Neurath; Leena Bruckner-Tuderman; Cassian Sitaru
Journal:  BMC Immunol       Date:  2012-04-04       Impact factor: 3.615

6.  Clinical presentation, pathogenesis, diagnosis, and treatment of epidermolysis bullosa acquisita.

Authors:  Ralf J Ludwig
Journal:  ISRN Dermatol       Date:  2013-07-15

7.  Metabolite analysis distinguishes between mice with epidermolysis bullosa acquisita and healthy mice.

Authors:  Sarah Schönig; Andreas Recke; Misa Hirose; Ralf J Ludwig; Karsten Seeger
Journal:  Orphanet J Rare Dis       Date:  2013-06-26       Impact factor: 4.123

8.  T cells mediate autoantibody-induced cutaneous inflammation and blistering in epidermolysis bullosa acquisita.

Authors:  Katja Bieber; Mareike Witte; Shijie Sun; Jennifer E Hundt; Kathrin Kalies; Sören Dräger; Anika Kasprick; Trix Twelkmeyer; Rudolf A Manz; Peter König; Jörg Köhl; Detlef Zillikens; Ralf J Ludwig
Journal:  Sci Rep       Date:  2016-12-05       Impact factor: 4.379

9.  Blister-inducing antibodies target multiple epitopes on collagen VII in mice.

Authors:  Kinga Csorba; Mircea Teodor Chiriac; Florina Florea; Miruna Georgiana Ghinia; Emilia Licarete; Andreea Rados; Alexandra Sas; Vlad Vuta; Cassian Sitaru
Journal:  J Cell Mol Med       Date:  2014-08-05       Impact factor: 5.310

10.  Autoimmunity and Cytokine Imbalance in Inherited Epidermolysis Bullosa.

Authors:  Susanna Esposito; Sophie Guez; Annalisa Orenti; Gianluca Tadini; Giulietta Scuvera; Laura Corti; Alessia Scala; Elia Biganzoli; Emilio Berti; Nicola Principi
Journal:  Int J Mol Sci       Date:  2016-09-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.